More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases

Generic Pharmaceuticals Price Fixing
Antitrust, Health Care, Healthcare
Lowey Dannenberg represents 34 of the nation’s largest health insurers, including Elevance Health (formerly known as Anthem), Aetna, Humana, and 25 BlueCross BlueShield licensees in connection with their claims relating […]

Swiss Franc LIBOR
Antitrust
Lowey Dannenberg is the court-appointed sole lead counsel in a class action against numerous global financial institutions responsible for setting the London Interbank Offered Rate for the Swiss Franc (Swiss […]

Euribor
Antitrust
Lowey Dannenberg is leading the prosecution against the global financial institutions responsible for the setting of the Euro Interbank Offered Rate (“Euribor”), a global reference rate used to benchmark, price […]
News
Lowey Secures Preliminary Approval of $60 Million Settlement in In re JPMorgan Precious Metals Spoofing Litigation
On December 20, 2021, Judge Gregory H. Woods of the United States Court for the Southern District of New York granted preliminary approval of a $60 million dollar settlement in in In re JPMorgan Precious Metals Spoofing Litigation, 18-cv-10356 (S.D.N.Y.). This settlement resolves claims against JPMorgan for the alleged manipulation of the precious metals futures market.
Blog
SEC Revives Claw Back Rule for Executive Compensation
Securities and Exchange Commission voted on October 14, 2021 to bring back an unfinished rule from 2015[1] relating to executive compensation. The rule requires U.S. listed companies to have a plan in place to claw back executive compensation in the event the company corrects their financial…





